Concepedia

Judy Doto

JD

Statistics

Publications

4

Citations

344

H-Index

4

Active since

2007

Affiliations

Sensei Biotherapeutics (United States)(Current)

IQVIA (United States)

Buffalo BioLabs

Judy Doto is an author at Sensei Biotherapeutics (United States) specializing in pharmacology, pharmacokinetics of antiretroviral drugs, and pharmacokinetics.

Publications per year

2007–2009

4

Publications

4

Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-<i>O</i>-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection

Patrick F. Smith, Abayomi Ogundele, Alan Forrest et al. · Antimicrobial Agents and Chemotherapy · 2007 · 192 citations · Full text

, , +17

Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

David E. Martin, Robert A. Blum, John H. Wilton et al. · Antimicrobial Agents and Chemotherapy · 2007 · 75 citations · Full text

, , +16

Multiple-Dose Pharmacokinetics and??Safety of Bevirimat, a??Novel??Inhibitor??of??HIV Maturation,??in??Healthy??Volunteers

David E. Martin, Robert A. Blum, Judy Doto et al. · Clinical Pharmacokinetics · 2007 · 52 citations

, , +14

An Oral Human Drug Absorption Study to Assess the Impact of Site of Delivery on the Bioavailability of Bevirimat

Alyson Connor, Phil Evans, Judy Doto et al. · The Journal of Clinical Pharmacology · 2009 · 25 citations

, , +17

1–4 of 4